HEADER VIRUS/VIRAL PROTEIN 26-APR-99 1RUX OBSLTE 11-NOV-03 1RUX 1P30 TITLE MAXIMUM LIKELIHOOD REFINEMENT OF ADENOVIRUS TYPE 5 HEXON TITLE 2 WITH TNT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (HEXON PROTEIN); COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN ADENOVIRUS TYPE 5; SOURCE 3 CELL_LINE: HELA S3; SOURCE 4 COLLECTION: ATCC VR-5; SOURCE 5 OTHER_DETAILS: VIRUS PROPAGATED IN HELA S3 CELLS (ATCC CCL SOURCE 6 2.2) KEYWDS ADENOVIRUS, TYPE 5, HEXON, VIRUS, MAXIMUM LIKELIHOOD, TNT, KEYWDS 2 JELLYROLL, COAT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.J.RUX,R.M.BURNETT REVDAT 4 11-NOV-03 1RUX 1 OBSLTE REVDAT 3 01-APR-03 1RUX 1 JRNL REVDAT 2 23-MAY-00 1RUX 1 DBREF REMARK REVDAT 1 20-MAR-00 1RUX 0 JRNL AUTH J.J.RUX,R.M.BURNETT JRNL TITL TYPE-SPECIFIC EPITOPE LOCATIONS REVEALED BY X-RAY JRNL TITL 2 CRYSTALLOGRAPHIC STUDY OF ADENOVIRUS TYPE 5 HEXON. JRNL REF MOL.THER. V. 1 18 2000 JRNL REFN US ISSN 1525-0016 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.RUX,D.PASCOLINI,R.M.BURNETT REMARK 1 TITL LARGE-SCALE PURIFICATION AND CRYSTALLIZATION OF REMARK 1 TITL 2 ADENOVIRUS HEXON (IN: METHODS IN MOLECULAR REMARK 1 TITL 3 MEDICINE) REMARK 1 EDIT W.S.M.WOLD REMARK 1 REF ADENOVIRUS METHODS AND 259 1998 REMARK 1 REF 2 PROTOCOLS REMARK 1 PUBL TOTOWA, NJ : HUMANA PRESS REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH F.K.ATHAPPILLY,R.MURALI,J.J.RUX,Z.CAI,R.M.BURNETT REMARK 1 TITL THE REFINED CRYSTAL STRUCTURE OF HEXON, THE MAJOR REMARK 1 TITL 2 COAT PROTEIN OF ADENOVIRUS TYPE 2, AT 2.9 REMARK 1 TITL 3 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 242 430 1994 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH P.L.STEWART,S.D.FULLER,R.M.BURNETT REMARK 1 TITL DIFFERENCE IMAGING OF ADENOVIRUS: BRIDGING THE REMARK 1 TITL 2 RESOLUTION GAP BETWEEN X-RAY CRYSTALLOGRAPHY AND REMARK 1 TITL 3 ELECTRON MICROSCOPY REMARK 1 REF EMBO J. V. 12 2589 1993 REMARK 1 REFN ASTM EMJODG UK ISSN 0261-4189 REMARK 1 REFERENCE 4 REMARK 1 AUTH P.L.STEWART,R.M.BURNETT,M.CYRKLAFF,S.D.FULLER REMARK 1 TITL IMAGE RECONSTRUCTION REVEALS THE COMPLEX MOLECULAR REMARK 1 TITL 2 ORGANIZATION OF THE ADENOVIRUS REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 67 145 1991 REMARK 1 REFN ASTM CELLB5 US ISSN 0092-8674 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5E REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 36549 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD :THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION :NULL REMARK 3 R VALUE (WORKING + TEST SET) :NULL REMARK 3 R VALUE (WORKING SET) :0.176 REMARK 3 FREE R VALUE :0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) :5.000 REMARK 3 FREE R VALUE TEST SET COUNT :1823 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1760 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1823 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 36549 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6942 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 25.700 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.004 ; 0.800 ; 7133 REMARK 3 BOND ANGLES (DEGREES) : 1.444 ; 1.300 ; 9671 REMARK 3 TORSION ANGLES (DEGREES) : 18.600; 0.000 ; 4069 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.003 ; 2.000 ; 174 REMARK 3 GENERAL PLANES (A) : 0.006 ; 5.000 ; 1049 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 1.765 ; 1.000 ; 7142 REMARK 3 NON-BONDED CONTACTS (A) : 0.059 ; 10.000; 96 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABENET SCALING REMARK 3 KSOL : 0.70 REMARK 3 BSOL : 203.00 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT PROTGEO REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT BCORREL V1.0 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE TNT PROGRAM WAS MODIFIED TO REMARK 3 INCLUDE THE MLF1 MAXIMUM LIKELIHOOD TARGET FUNCTION OF PANNU REMARK 3 AND READ (1996). REMARK 4 REMARK 4 1RUX COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 6 REMARK 6 TER REMARK 6 THR: THE C-TERMINAL RESIDUE WAS NOT SEEN IN THE DENSITY MAP REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-APR-1999. REMARK 100 THE RCSB ID CODE IS RCSB000946. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-1994 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 3.20 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS MULTIWIRE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38496 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.23400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: TNT REMARK 200 STARTING MODEL: PDB ENTRY 1DHX REMARK 200 REMARK 200 REMARK: AD2 HEXON (1DHX) MODEL WAS FURTHER REFINED TO 2.3 REMARK 200 ANGSTROMS RESOLUTION BEFORE USE AS STARTING MODEL. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 UL HANGING DROP CONTAINING 5 UL REMARK 280 (10.6 MG/ML) PROTEIN AND 5 UL OF THE 1 ML ( 1.0 M SODIUM REMARK 280 CITRATE PH 3.2) RESERVOIR SOLUTION., PH 3.20 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 1/2+Z,1/2-X,-Y REMARK 290 7555 1/2-Z,-X,1/2+Y REMARK 290 8555 -Z,1/2+X,1/2-Y REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,1/2+Z,1/2-X REMARK 290 11555 1/2+Y,1/2-Z,-X REMARK 290 12555 1/2-Y,-Z,1/2+X REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 75.35000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 75.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 75.35000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 75.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 75.35000 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 75.35000 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 75.35000 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 75.35000 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 75.35000 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 75.35000 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 75.35000 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 75.35000 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 75.35000 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 75.35000 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 75.35000 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 75.35000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 THR A 2 REMARK 465 PRO A 3 REMARK 465 SER A 4 REMARK 465 GLU A 136 REMARK 465 ALA A 137 REMARK 465 ALA A 138 REMARK 465 THR A 139 REMARK 465 ALA A 140 REMARK 465 LEU A 141 REMARK 465 GLU A 142 REMARK 465 ILE A 143 REMARK 465 ASN A 144 REMARK 465 LEU A 145 REMARK 465 GLU A 146 REMARK 465 GLU A 147 REMARK 465 GLU A 148 REMARK 465 ASP A 149 REMARK 465 ASP A 150 REMARK 465 ASP A 151 REMARK 465 ASN A 152 REMARK 465 GLU A 153 REMARK 465 ASP A 154 REMARK 465 GLU A 155 REMARK 465 VAL A 156 REMARK 465 ASP A 157 REMARK 465 GLU A 158 REMARK 465 GLN A 159 REMARK 465 ALA A 160 REMARK 465 GLU A 161 REMARK 465 GLN A 162 REMARK 465 GLN A 163 REMARK 465 LYS A 164 REMARK 465 VAL A 187 REMARK 465 GLU A 188 REMARK 465 GLY A 189 REMARK 465 GLN A 190 REMARK 465 THR A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 251 REMARK 465 GLN A 252 REMARK 465 GLN A 253 REMARK 465 ASN A 254 REMARK 465 GLY A 255 REMARK 465 LYS A 256 REMARK 465 LEU A 257 REMARK 465 GLU A 270 REMARK 465 ALA A 271 REMARK 465 THR A 272 REMARK 465 ALA A 273 REMARK 465 GLY A 274 REMARK 465 ASN A 275 REMARK 465 GLY A 276 REMARK 465 ASP A 277 REMARK 465 LYS A 431 REMARK 465 THR A 432 REMARK 465 GLY A 433 REMARK 465 GLN A 434 REMARK 465 GLU A 435 REMARK 465 ASN A 436 REMARK 465 THR A 443 REMARK 465 GLU A 444 REMARK 465 GLY A 947 REMARK 465 ASN A 948 REMARK 465 ALA A 949 REMARK 465 THR A 950 REMARK 465 THR A 951 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 5 CG SD CE REMARK 470 GLN A 29 CG CD OE1 NE2 REMARK 470 ARG A 32 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 35 CG CD OE1 OE2 REMARK 470 ASN A 41 CG OD1 ND2 REMARK 470 ARG A 72 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 177 CG OD1 ND2 REMARK 470 THR A 179 OG1 CG2 REMARK 470 LYS A 180 CG CD CE NZ REMARK 470 LYS A 193 CG CD CE NZ REMARK 470 TYR A 194 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 197 CG CD CE NZ REMARK 470 GLU A 207 CG CD OE1 OE2 REMARK 470 SER A 208 OG REMARK 470 GLN A 209 CG CD OE1 NE2 REMARK 470 GLU A 212 CG CD OE1 OE2 REMARK 470 THR A 213 OG1 CG2 REMARK 470 GLU A 214 CG CD OE1 OE2 REMARK 470 ILE A 215 CG1 CG2 CD1 REMARK 470 GLU A 242 CG CD OE1 OE2 REMARK 470 GLU A 258 CG CD OE1 OE2 REMARK 470 GLU A 262 CG CD OE1 OE2 REMARK 470 THR A 269 OG1 CG2 REMARK 470 ASN A 278 CG OD1 ND2 REMARK 470 LEU A 279 CG CD1 CD2 REMARK 470 THR A 280 OG1 CG2 REMARK 470 LYS A 282 CG CD CE NZ REMARK 470 ILE A 305 CG1 CG2 CD1 REMARK 470 LYS A 306 CG CD CE NZ REMARK 470 GLU A 307 CG CD OE1 OE2 REMARK 470 ARG A 311 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 312 CG CD OE1 OE2 REMARK 470 SER A 340 OG REMARK 470 SER A 352 OG REMARK 470 GLN A 353 CG CD OE1 NE2 REMARK 470 LYS A 429 CG CD CE NZ REMARK 470 GLU A 439 CG CD OE1 OE2 REMARK 470 LYS A 440 CG CD CE NZ REMARK 470 SER A 446 OG REMARK 470 LYS A 448 CG CD CE NZ REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 LYS A 685 CG CD CE NZ REMARK 470 SER A 726 OG REMARK 470 SER A 747 OG REMARK 470 ASP A 749 CG OD1 OD2 REMARK 470 GLU A 784 CG CD OE1 OE2 REMARK 470 LYS A 809 CG CD CE NZ REMARK 470 LYS A 811 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 556 N - CA - C ANGL. DEV. =-10.1 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 748 -57.98 44.60 REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 1178 DISTANCE = 5.20 ANGSTROMS DBREF 1RUX A 1 951 UNP P04133 HEX_ADE05 1 951 SEQRES 1 A 951 ALA THR PRO SER MET MET PRO GLN TRP SER TYR MET HIS SEQRES 2 A 951 ILE SER GLY GLN ASP ALA SER GLU TYR LEU SER PRO GLY SEQRES 3 A 951 LEU VAL GLN PHE ALA ARG ALA THR GLU THR TYR PHE SER SEQRES 4 A 951 LEU ASN ASN LYS PHE ARG ASN PRO THR VAL ALA PRO THR SEQRES 5 A 951 HIS ASP VAL THR THR ASP ARG SER GLN ARG LEU THR LEU SEQRES 6 A 951 ARG PHE ILE PRO VAL ASP ARG GLU ASP THR ALA TYR SER SEQRES 7 A 951 TYR LYS ALA ARG PHE THR LEU ALA VAL GLY ASP ASN ARG SEQRES 8 A 951 VAL LEU ASP MET ALA SER THR TYR PHE ASP ILE ARG GLY SEQRES 9 A 951 VAL LEU ASP ARG GLY PRO THR PHE LYS PRO TYR SER GLY SEQRES 10 A 951 THR ALA TYR ASN ALA LEU ALA PRO LYS GLY ALA PRO ASN SEQRES 11 A 951 PRO CYS GLU TRP ASP GLU ALA ALA THR ALA LEU GLU ILE SEQRES 12 A 951 ASN LEU GLU GLU GLU ASP ASP ASP ASN GLU ASP GLU VAL SEQRES 13 A 951 ASP GLU GLN ALA GLU GLN GLN LYS THR HIS VAL PHE GLY SEQRES 14 A 951 GLN ALA PRO TYR SER GLY ILE ASN ILE THR LYS GLU GLY SEQRES 15 A 951 ILE GLN ILE GLY VAL GLU GLY GLN THR PRO LYS TYR ALA SEQRES 16 A 951 ASP LYS THR PHE GLN PRO GLU PRO GLN ILE GLY GLU SER SEQRES 17 A 951 GLN TRP TYR GLU THR GLU ILE ASN HIS ALA ALA GLY ARG SEQRES 18 A 951 VAL LEU LYS LYS THR THR PRO MET LYS PRO CYS TYR GLY SEQRES 19 A 951 SER TYR ALA LYS PRO THR ASN GLU ASN GLY GLY GLN GLY SEQRES 20 A 951 ILE LEU VAL LYS GLN GLN ASN GLY LYS LEU GLU SER GLN SEQRES 21 A 951 VAL GLU MET GLN PHE PHE SER THR THR GLU ALA THR ALA SEQRES 22 A 951 GLY ASN GLY ASP ASN LEU THR PRO LYS VAL VAL LEU TYR SEQRES 23 A 951 SER GLU ASP VAL ASP ILE GLU THR PRO ASP THR HIS ILE SEQRES 24 A 951 SER TYR MET PRO THR ILE LYS GLU GLY ASN SER ARG GLU SEQRES 25 A 951 LEU MET GLY GLN GLN SER MET PRO ASN ARG PRO ASN TYR SEQRES 26 A 951 ILE ALA PHE ARG ASP ASN PHE ILE GLY LEU MET TYR TYR SEQRES 27 A 951 ASN SER THR GLY ASN MET GLY VAL LEU ALA GLY GLN ALA SEQRES 28 A 951 SER GLN LEU ASN ALA VAL VAL ASP LEU GLN ASP ARG ASN SEQRES 29 A 951 THR GLU LEU SER TYR GLN LEU LEU LEU ASP SER ILE GLY SEQRES 30 A 951 ASP ARG THR ARG TYR PHE SER MET TRP ASN GLN ALA VAL SEQRES 31 A 951 ASP SER TYR ASP PRO ASP VAL ARG ILE ILE GLU ASN HIS SEQRES 32 A 951 GLY THR GLU ASP GLU LEU PRO ASN TYR CYS PHE PRO LEU SEQRES 33 A 951 GLY GLY VAL ILE ASN THR GLU THR LEU THR LYS VAL LYS SEQRES 34 A 951 PRO LYS THR GLY GLN GLU ASN GLY TRP GLU LYS ASP ALA SEQRES 35 A 951 THR GLU PHE SER ASP LYS ASN GLU ILE ARG VAL GLY ASN SEQRES 36 A 951 ASN PHE ALA MET GLU ILE ASN LEU ASN ALA ASN LEU TRP SEQRES 37 A 951 ARG ASN PHE LEU TYR SER ASN ILE ALA LEU TYR LEU PRO SEQRES 38 A 951 ASP LYS LEU LYS TYR SER PRO SER ASN VAL LYS ILE SER SEQRES 39 A 951 ASP ASN PRO ASN THR TYR ASP TYR MET ASN LYS ARG VAL SEQRES 40 A 951 VAL ALA PRO GLY LEU VAL ASP CYS TYR ILE ASN LEU GLY SEQRES 41 A 951 ALA ARG TRP SER LEU ASP TYR MET ASP ASN VAL ASN PRO SEQRES 42 A 951 PHE ASN HIS HIS ARG ASN ALA GLY LEU ARG TYR ARG SER SEQRES 43 A 951 MET LEU LEU GLY ASN GLY ARG TYR VAL PRO PHE HIS ILE SEQRES 44 A 951 GLN VAL PRO GLN LYS PHE PHE ALA ILE LYS ASN LEU LEU SEQRES 45 A 951 LEU LEU PRO GLY SER TYR THR TYR GLU TRP ASN PHE ARG SEQRES 46 A 951 LYS ASP VAL ASN MET VAL LEU GLN SER SER LEU GLY ASN SEQRES 47 A 951 ASP LEU ARG VAL ASP GLY ALA SER ILE LYS PHE ASP SER SEQRES 48 A 951 ILE CYS LEU TYR ALA THR PHE PHE PRO MET ALA HIS ASN SEQRES 49 A 951 THR ALA SER THR LEU GLU ALA MET LEU ARG ASN ASP THR SEQRES 50 A 951 ASN ASP GLN SER PHE ASN ASP TYR LEU SER ALA ALA ASN SEQRES 51 A 951 MET LEU TYR PRO ILE PRO ALA ASN ALA THR ASN VAL PRO SEQRES 52 A 951 ILE SER ILE PRO SER ARG ASN TRP ALA ALA PHE ARG GLY SEQRES 53 A 951 TRP ALA PHE THR ARG LEU LYS THR LYS GLU THR PRO SER SEQRES 54 A 951 LEU GLY SER GLY TYR ASP PRO TYR TYR THR TYR SER GLY SEQRES 55 A 951 SER ILE PRO TYR LEU ASP GLY THR PHE TYR LEU ASN HIS SEQRES 56 A 951 THR PHE LYS LYS VAL ALA ILE THR PHE ASP SER SER VAL SEQRES 57 A 951 SER TRP PRO GLY ASN ASP ARG LEU LEU THR PRO ASN GLU SEQRES 58 A 951 PHE GLU ILE LYS ARG SER VAL ASP GLY GLU GLY TYR ASN SEQRES 59 A 951 VAL ALA GLN CYS ASN MET THR LYS ASP TRP PHE LEU VAL SEQRES 60 A 951 GLN MET LEU ALA ASN TYR ASN ILE GLY TYR GLN GLY PHE SEQRES 61 A 951 TYR ILE PRO GLU SER TYR LYS ASP ARG MET TYR SER PHE SEQRES 62 A 951 PHE ARG ASN PHE GLN PRO MET SER ARG GLN VAL VAL ASP SEQRES 63 A 951 ASP THR LYS TYR LYS ASP TYR GLN GLN VAL GLY ILE LEU SEQRES 64 A 951 HIS GLN HIS ASN ASN SER GLY PHE VAL GLY TYR LEU ALA SEQRES 65 A 951 PRO THR MET ARG GLU GLY GLN ALA TYR PRO ALA ASN PHE SEQRES 66 A 951 PRO TYR PRO LEU ILE GLY LYS THR ALA VAL ASP SER ILE SEQRES 67 A 951 THR GLN LYS LYS PHE LEU CYS ASP ARG THR LEU TRP ARG SEQRES 68 A 951 ILE PRO PHE SER SER ASN PHE MET SER MET GLY ALA LEU SEQRES 69 A 951 THR ASP LEU GLY GLN ASN LEU LEU TYR ALA ASN SER ALA SEQRES 70 A 951 HIS ALA LEU ASP MET THR PHE GLU VAL ASP PRO MET ASP SEQRES 71 A 951 GLU PRO THR LEU LEU TYR VAL LEU PHE GLU VAL PHE ASP SEQRES 72 A 951 VAL VAL ARG VAL HIS ARG PRO HIS ARG GLY VAL ILE GLU SEQRES 73 A 951 THR VAL TYR LEU ARG THR PRO PHE SER ALA GLY ASN ALA SEQRES 74 A 951 THR THR FORMUL 2 HOH *247(H2 O1) HELIX 1 1 MET A 6 TYR A 11 1 6 HELIX 2 2 ALA A 19 TYR A 22 1 4 HELIX 3 3 PRO A 25 THR A 34 1 10 HELIX 4 4 ASN A 41 LYS A 43 5 3 HELIX 5 5 MET A 95 SER A 97 5 3 HELIX 6 6 ARG A 311 GLY A 315 5 5 HELIX 7 7 ASP A 330 PHE A 332 5 3 HELIX 8 8 THR A 341 ASN A 343 5 3 HELIX 9 9 THR A 365 ILE A 376 1 12 HELIX 10 10 SER A 384 TRP A 386 5 3 HELIX 11 11 PRO A 395 ARG A 398 1 4 HELIX 12 12 LEU A 463 ASN A 475 1 13 HELIX 13 13 ALA A 477 TYR A 479 5 3 HELIX 14 14 ASP A 482 LEU A 484 5 3 HELIX 15 15 TYR A 500 LYS A 505 1 6 HELIX 16 16 PRO A 510 VAL A 513 5 4 HELIX 17 17 ALA A 540 LEU A 549 1 10 HELIX 18 18 VAL A 588 VAL A 591 1 4 HELIX 19 19 HIS A 623 ARG A 634 1 12 HELIX 20 20 ASP A 636 ASN A 638 5 3 HELIX 21 21 THR A 684 GLU A 686 5 3 HELIX 22 22 PRO A 705 ASP A 708 1 4 HELIX 23 23 ASN A 714 THR A 716 5 3 HELIX 24 24 GLU A 751 TYR A 753 5 3 HELIX 25 25 LYS A 762 TYR A 773 1 12 HELIX 26 26 PHE A 794 ASN A 796 5 3 HELIX 27 27 ILE A 818 HIS A 820 5 3 HELIX 28 28 LEU A 891 ALA A 894 1 4 SHEET 1 A 4 THR A 64 ILE A 68 0 SHEET 2 A 4 SER A 606 THR A 617 -1 N ALA A 616 O LEU A 65 SHEET 3 A 4 THR A 98 ASP A 107 -1 N ASP A 107 O SER A 606 SHEET 4 A 4 TYR A 554 PRO A 562 -1 N VAL A 561 O PHE A 100 SHEET 1 B 4 ASP A 71 ASP A 74 0 SHEET 2 B 4 SER A 78 VAL A 87 -1 N ARG A 82 O ASP A 71 SHEET 3 B 4 GLY A 576 ARG A 585 -1 N PHE A 584 O TYR A 79 SHEET 4 B 4 VAL A 346 GLY A 349 -1 N ALA A 348 O THR A 579 SHEET 1 C 2 CYS A 132 TRP A 134 0 SHEET 2 C 2 HIS A 166 PHE A 168 -1 N PHE A 168 O CYS A 132 SHEET 1 D 3 ALA A 218 LEU A 223 0 SHEET 2 D 3 VAL A 283 GLU A 288 1 N VAL A 284 O ALA A 218 SHEET 3 D 3 GLU A 262 PHE A 266 -1 N PHE A 266 O VAL A 283 SHEET 1 E 2 ILE A 326 PHE A 328 0 SHEET 2 E 2 LEU A 592 SER A 594 -1 N GLN A 593 O ALA A 327 SHEET 1 F 2 TYR A 412 PHE A 414 0 SHEET 2 F 2 ALA A 458 GLU A 460 -1 N MET A 459 O CYS A 413 SHEET 1 G 2 GLU A 423 LEU A 425 0 SHEET 2 G 2 ASN A 449 ILE A 451 -1 N ILE A 451 O GLU A 423 SHEET 1 H 3 GLN A 640 ASN A 643 0 SHEET 2 H 3 PHE A 922 HIS A 928 -1 N VAL A 927 O GLN A 640 SHEET 3 H 3 GLU A 936 THR A 942 -1 N THR A 942 O PHE A 922 SHEET 1 I 4 ALA A 648 ILE A 655 0 SHEET 2 I 4 THR A 913 GLU A 920 -1 N PHE A 919 O ALA A 649 SHEET 3 I 4 GLY A 676 LYS A 683 -1 N LEU A 682 O LEU A 914 SHEET 4 I 4 TRP A 870 PRO A 873 -1 N ILE A 872 O TRP A 677 SHEET 1 J 4 ASN A 661 ILE A 666 0 SHEET 2 J 4 LEU A 900 VAL A 906 -1 N PHE A 904 O VAL A 662 SHEET 3 J 4 PHE A 717 PHE A 724 -1 N THR A 723 O ASP A 901 SHEET 4 J 4 VAL A 728 TRP A 730 -1 N TRP A 730 O ILE A 722 SHEET 1 K 2 PHE A 797 VAL A 805 0 SHEET 2 K 2 SER A 857 CYS A 865 -1 N LEU A 864 O GLN A 798 SHEET 1 L 2 THR A 297 TYR A 301 0 SHEET 2 L 2 GLN A 317 PRO A 320 -1 N MET A 319 O HIS A 298 CISPEP 1 GLN A 200 PRO A 201 0 1.21 CISPEP 2 TRP A 730 PRO A 731 0 3.44 CISPEP 3 PHE A 845 PRO A 846 0 1.31 CISPEP 4 THR A 942 PRO A 943 0 -1.13 CRYST1 150.700 150.700 150.700 90.00 90.00 90.00 P 21 3 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006636 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006636 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006636 0.00000